SoylentNews is people
SoylentNews
Arthur T Knackerbracket has found the following story:
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).
Although there was no active viral infection in the patient's body, remnants of integrated HIV-1 DNA remained in tissue samples, which were also found in the first patient to be cured of HIV. The authors suggest that these can be regarded as so-called 'fossils', as they are unlikely to be capable of reproducing the virus.
Lead author on the study, Professor Ravindra Kumar Gupta, University of Cambridge, UK, says: "We propose that these results represent the second ever case of a patient to be cured of HIV. Our findings show that the success of stem cell transplantation as a cure for HIV, first reported nine years ago in the Berlin patient, can be replicated."
He cautions: "It is important to note that this curative treatment is high-risk, and only used as a last resort for patients with HIV who also have life-threatening haematological malignancies. Therefore, this is not a treatment that would be offered widely to patients with HIV who are on successful antiretroviral treatment.
-- submitted from IRC
Ravindra Kumar Gupta, Et Al. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report. The Lancet HIV, 2020; DOI: 10.1016/S2352-3018(20)30069-2
(Score: 1) by shrewdsheep on Monday March 16 2020, @04:50PM
While the successes shown for the two patients so far certainly stand on their own and are undisputed, there is a longer term risk not mentioned. HIV is a retrovirus integrating into host DNA. It is therefore replicated in inactive state in host cells when they divide and can be re-activated at any moment. The two transplant patients certainly still carry HIV in their bodies, when re-activated the viruses just happen not be to able to infect new T-cells. HIV does not only infect T-cells and there might be a slow continuation of undetected virus spread in the body. While these patients are likely to do well, it is important to monitor them long term IMO (10, 20 yrs).
HIV is still a virus you might not want to contract.